Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Results from phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years or older
2
FDA accepts centanafadine NDA for priority review for ADHD in children, adolescents
3
Five youth suicide profiles identified to improve prevention efforts
4
Weekly review: Well visits, HIV therapy, and more
5